サマリー

硫酸キニジンの世界市場 2022-2026 年
Technavioはキニジン硫酸塩市場を監視しており、2022-2026年の間に427.29百万ドル、予測期間中にCAGR6.7％で加速して成長すると予測しています。当レポートでは、キニジン硫酸市場の全体分析、市場規模と予測、トレンド、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを提供しています。
また、現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境についての最新分析を提供しています。市場は、マラリアの発生率の増加、堅調なパイプラインと医薬品承認、M&Aの増加によって牽引されています。
硫酸キニジン市場の分析には、タイプ別セグメントと地理的展望が含まれます。
Technavioのキニジン硫酸塩市場は以下のように区分されています。
タイプ別
- マラリア
- 不整脈
地域別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間におけるキニジン硫酸塩市場の成長を促進する主な理由の1つとして、マラリア撲滅のための強力な資金調達を挙げています。また、不整脈の発生率の増加や、硫酸キニジンサプリメントに関する人々の意識の高まりは、市場での大きな需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。硫酸キニジン市場に関する当レポートは、以下の分野を対象としています。
- 硫酸キニジンの市場サイジング
- 硫酸キニジン市場予測
- 硫酸キニジン市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Bennet Pharmaceuticals Ltd., Buchler GmbH, Cipla Ltd., Ipca Laboratories Ltd., Lark Laboratories India Ltd., Merck and Co., Ltd.など、いくつかの主要キニジン硫酸市場ベンダーに関する詳細分析を提供しています。Inc.、Merck KGaA、PRISM INDUSTRIES LTD.、Teva Pharmaceutical Industries Ltd.、VIVAN Life Sciences Pvt.Ltd., Biophore India Pharmaceuticals Pvt.Ltd., Inga Laboratories P. Ltd., Koninklijke DSM NV, PMC Group Inc.、PT Bio Farma, PT Sinkona Indonesia lestarおよび Vital Laboratories Pvt.Ltd. などです。また、硫酸キニジン市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/quinidine-sulfate-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータを調査、合成、総括することで、市場の詳細なイメージを提示します。業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Disease Type
o 5.1 Market segments
o Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
o 5.2 Comparison by Disease Type
o Exhibit 26: Chart on Comparison by Disease Type
o Exhibit 27: Data Table on Comparison by Disease Type
o 5.3 Malaria - Market size and forecast 2021-2026
o Exhibit 28: Chart on Malaria - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Malaria - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Malaria - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Malaria - Year-over-year growth 2021-2026 (%)
o 5.4 Arrhythmias - Market size and forecast 2021-2026
o Exhibit 32: Chart on Arrhythmias - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Arrhythmias - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Arrhythmias - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Arrhythmias - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Disease Type
o Exhibit 36: Market opportunity by Disease Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 UK - Market size and forecast 2021-2026
o Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Bennet Pharmaceuticals Ltd.
o Exhibit 85: Bennet Pharmaceuticals Ltd. - Overview
o Exhibit 86: Bennet Pharmaceuticals Ltd. - Product / Service
o Exhibit 87: Bennet Pharmaceuticals Ltd. - Key offerings
o 10.4 Buchler GmbH
o Exhibit 88: Buchler GmbH - Overview
o Exhibit 89: Buchler GmbH - Product / Service
o Exhibit 90: Buchler GmbH - Key offerings
o 10.5 Cipla Ltd.
o Exhibit 91: Cipla Ltd. - Overview
o Exhibit 92: Cipla Ltd. - Business segments
o Exhibit 93: Cipla Ltd. - Key news
o Exhibit 94: Cipla Ltd. - Key offerings
o Exhibit 95: Cipla Ltd. - Segment focus
o 10.6 Ipca Laboratories Ltd.
o Exhibit 96: Ipca Laboratories Ltd. - Overview
o Exhibit 97: Ipca Laboratories Ltd. - Product / Service
o Exhibit 98: Ipca Laboratories Ltd. - Key offerings
o 10.7 Lark Laboratories India Ltd.
o Exhibit 99: Lark Laboratories India Ltd. - Overview
o Exhibit 100: Lark Laboratories India Ltd. - Product / Service
o Exhibit 101: Lark Laboratories India Ltd. - Key offerings
o 10.8 Merck and Co. Inc.
o Exhibit 102: Merck and Co. Inc. - Overview
o Exhibit 103: Merck and Co. Inc. - Business segments
o Exhibit 104: Merck and Co. Inc. - Key news
o Exhibit 105: Merck and Co. Inc. - Key offerings
o Exhibit 106: Merck and Co. Inc. - Segment focus
o 10.9 Merck KGaA
o Exhibit 107: Merck KGaA - Overview
o Exhibit 108: Merck KGaA - Business segments
o Exhibit 109: Merck KGaA - Key news
o Exhibit 110: Merck KGaA - Key offerings
o Exhibit 111: Merck KGaA - Segment focus
o 10.10 PRISM INDUSTRIES LTD.
o Exhibit 112: PRISM INDUSTRIES LTD. - Overview
o Exhibit 113: PRISM INDUSTRIES LTD. - Product / Service
o Exhibit 114: PRISM INDUSTRIES LTD. - Key offerings
o 10.11 Teva Pharmaceutical Industries Ltd.
o Exhibit 115: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 116: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 117: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 118: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 119: Teva Pharmaceutical Industries Ltd. - Segment focus
o 10.12 VIVAN Life Sciences Pvt. Ltd.
o Exhibit 120: VIVAN Life Sciences Pvt. Ltd. - Overview
o Exhibit 121: VIVAN Life Sciences Pvt. Ltd. - Product / Service
o Exhibit 122: VIVAN Life Sciences Pvt. Ltd. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 123: Inclusions checklist
o Exhibit 124: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 125: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 126: Research methodology
o Exhibit 127: Validation techniques employed for market sizing
o Exhibit 128: Information sources
o 11.5 List of abbreviations
o Exhibit 129: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Disease Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Disease Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Disease Type
Exhibits27: Data Table on Comparison by Disease Type
Exhibits28: Chart on Malaria - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Malaria - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Malaria - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Malaria - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Arrhythmias - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Arrhythmias - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Arrhythmias - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Arrhythmias - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Disease Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Bennet Pharmaceuticals Ltd. - Overview
Exhibits86: Bennet Pharmaceuticals Ltd. - Product / Service
Exhibits87: Bennet Pharmaceuticals Ltd. - Key offerings
Exhibits88: Buchler GmbH - Overview
Exhibits89: Buchler GmbH - Product / Service
Exhibits90: Buchler GmbH - Key offerings
Exhibits91: Cipla Ltd. - Overview
Exhibits92: Cipla Ltd. - Business segments
Exhibits93: Cipla Ltd. - Key news
Exhibits94: Cipla Ltd. - Key offerings
Exhibits95: Cipla Ltd. - Segment focus
Exhibits96: Ipca Laboratories Ltd. - Overview
Exhibits97: Ipca Laboratories Ltd. - Product / Service
Exhibits98: Ipca Laboratories Ltd. - Key offerings
Exhibits99: Lark Laboratories India Ltd. - Overview
Exhibits100: Lark Laboratories India Ltd. - Product / Service
Exhibits101: Lark Laboratories India Ltd. - Key offerings
Exhibits102: Merck and Co. Inc. - Overview
Exhibits103: Merck and Co. Inc. - Business segments
Exhibits104: Merck and Co. Inc. - Key news
Exhibits105: Merck and Co. Inc. - Key offerings
Exhibits106: Merck and Co. Inc. - Segment focus
Exhibits107: Merck KGaA - Overview
Exhibits108: Merck KGaA - Business segments
Exhibits109: Merck KGaA - Key news
Exhibits110: Merck KGaA - Key offerings
Exhibits111: Merck KGaA - Segment focus
Exhibits112: PRISM INDUSTRIES LTD. - Overview
Exhibits113: PRISM INDUSTRIES LTD. - Product / Service
Exhibits114: PRISM INDUSTRIES LTD. - Key offerings
Exhibits115: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits116: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits117: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits118: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits119: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits120: VIVAN Life Sciences Pvt. Ltd. - Overview
Exhibits121: VIVAN Life Sciences Pvt. Ltd. - Product / Service
Exhibits122: VIVAN Life Sciences Pvt. Ltd. - Key offerings
Exhibits123: Inclusions checklist
Exhibits124: Exclusions checklist
Exhibits125: Currency conversion rates for US$
Exhibits126: Research methodology
Exhibits127: Validation techniques employed for market sizing
Exhibits128: Information sources
Exhibits129: List of abbreviations